Gregory B Brown is Director of CALADRIUS BIOSCIENCES, INC.. Currently has a direct ownership of 49,414 shares of CLBS, which is worth approximately $173,937. The most recent transaction as insider was on Jan 09, 2024, when has been sold 19,480 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.4K
0% 3M change
65.08% 12M change
Total Value Held $173,937

GREGORY B BROWN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2024
BUY
Grant, award, or other acquisition
-
19,480 Added 28.28%
49,414 Common Stock
Jan 09 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 40.05%
29,934 Common Stock
Jan 10 2022
BUY
Grant, award, or other acquisition
-
65,430 Added 30.51%
149,040 Common Stock
Jan 11 2021
BUY
Grant, award, or other acquisition
-
37,735 Added 31.1%
83,610 Common Stock

Also insider at

AQST
Aquestive Therapeutics, Inc. Healthcare
GBB

Gregory B Brown

Director
Basking Ridge, NJ

Track Institutional and Insider Activities on CLBS

Follow CALADRIUS BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLBS shares.

Notify only if

Insider Trading

Get notified when an Caladrius Biosciences, Inc. insider buys or sells CLBS shares.

Notify only if

News

Receive news related to CALADRIUS BIOSCIENCES, INC.

Track Activities on CLBS